scriptaid has been researched along with trichostatin a in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (33.33) | 29.6817 |
2010's | 17 (56.67) | 24.3611 |
2020's | 3 (10.00) | 2.80 |
Authors | Studies |
---|---|
Abou-Khalil, E; Allan, M; Beaulieu, C; Bernstein, N; Besterman, JM; Bouchain, G; Delorme, D; Fournel, M; Frechette, S; Kalita, A; Leit, S; Li, Z; MacLeod, AR; Moradei, O; Trachy-Bourget, MC; Vaisburg, A; Wang, J; Woo, SH; Yan, PT | 1 |
Adrián, F; Anderson, P; Brinker, A; Caldwell, JS; Chatterjee, A; Gray, NS; Henson, K; Janes, J; Kato, N; Kuhen, K; Matzen, JT; McNamara, C; Nagle, A; Nam, TG; Plouffe, D; Schultz, PG; Trager, R; Winzeler, EA; Yan, SF; Zhou, Y | 1 |
Balch, WE; Frizzell, RA; Gentzsch, M; Gottesfeld, JM; Herman, D; Hoch, B; Hutt, DM; Kellner, W; Kelly, JW; Lukacs, GL; Manning, G; Matsumura, Y; Matteson, J; Noel, S; Okiyoneda, T; Pilewski, JM; Riordan, JR; Rodrigues, AP; Schmidt, A; Skach, WR; Sorscher, EJ; Thomas, PJ; Yates, JR | 1 |
Bradner, JE; Grachan, ML; Greenberg, EF; Haggarty, SJ; Mazitschek, R; Warnow, T; West, N | 1 |
Cheng, F; Dong, N; Huang, J; Jiang, X; Li, J; Lin, P; Liu, M; Lu, W; Ouyang, P; Tang, Y; Wu, D; Wu, Z; Xu, Z; Yao, X; Zeng, M; Zhang, C; Zou, S | 1 |
Forgione, M; Hailu, GS; Mai, A; Robaa, D; Rotili, D; Sippl, W | 1 |
Ballante, F; Marshall, GR; Reddy, DR; Zhou, NJ | 1 |
Al-Mouhammad, H; Alami, M; Bauvais, C; Benihoud, K; Bignon, J; Bollot, G; Borgel, D; Dubois, J; Feuillard, J; Hamze, A; Jayat-Vignoles, C; Kasselouri, A; Lamaa, D; Levaique, H; Lin, HP; Ouaissi, M; Pamlard, O; Saller, F; Souce, M; Zig, L | 1 |
Ashton, TD; Devlin, M; Fleming, CL; Gibert, Y; Leslie, KG; Natoli, A; New, EJ; Pfeffer, FM; Schreuders, J; Yoganantharajah, P | 1 |
Brindisi, M; Brogi, S; Butini, S; Campiani, G; Gemma, S; Saraswati, AP | 1 |
Alami, M; Apcher, S; Askenatzis, L; Balcerowiak, C; Baschieri, F; Bauvais, C; Bignon, J; Blanchard, V; Bollot, G; Deroussent, A; Ducellier, S; Hamze, A; Hauguel, C; Ibrahim, N; Lafanechère, L; Laisne, MC; Lamaa, D; Letribot, B; Levaique, H; Michallet, S; Montagnac, G; Nascimento, M; Papot, S; Prost, B; Provot, O; Renko, D; Tran, C | 1 |
Kern, SE; Ryu, B; Sohn, TA; Su, GH | 1 |
Cao, H; Jung, M; Stamatoyannopoulos, G | 1 |
Baliga, BS; Hunter, R; Johnson, J; McElveen, R; Pace, BS; Qian, XH | 1 |
Berenji, K; Hill, JA; Kong, Y; Lu, G; Olson, EN; Rothermel, BA; Tannous, P | 1 |
Cassell, M; Lindsay, DS; Mitchell, SM; Reilly, CM; Strobl, JS | 1 |
Arnason, TG; Chik, CL; Dukewich, WG; Ho, AK; Price, DM; Steinberg, N | 1 |
Han, SB; Lee, JK | 1 |
Dagtas, AS; Edens, RE; Gilbert, KM | 1 |
Kubota, N; Kuribayashi, T; Ohara, M; Sora, S | 1 |
Hao, Y; Murphy, CN; Prather, RS; Rieke, A; Ross, JW; Samuel, MS; Spate, LD; Walters, EM; Zhao, J | 1 |
Akiba, N; Akiba, Y; Baker, H; Cave, JW; Langley, B; Ratan, RR | 1 |
Akagi, S; Fukunari, K; Kaneda, M; Matsukawa, K; Mizutani, E; Takahashi, S; Watanabe, S | 1 |
Li, W; Lou, TF; Mackie, A; Pace, B; Ramakrishnan, V; Sivanand, S; Zein, S | 1 |
Wan, YJ; Yang, H; Zhan, Q | 1 |
Bui, HT; Kim, JH; Park, JY; Park, MR; Seo, HJ; Thuan, NV; Wakayama, T | 1 |
Chang, WF; Chen, CH; Chen, YE; Cheng, WT; Du, F; Ju, JC; Lin, TA; Liu, CC; Su, HY; Sung, LY; Wu, SC; Xu, J | 1 |
Kim, YH; Lee, JK | 1 |
Alavanos, A; Andreatos, N; Angelou, A; Antoniou, EA; Apostolou, KG; Athanasiou, A; Damaskos, C; Damaskou, Z; Daskalopoulou, A; Diamantis, E; Dimitroulis, D; Garmpi, A; Garmpis, N; Kalampokas, E; Kalampokas, T; Kontzoglou, K; Kostakis, A; Lavaris, A; Mantas, D; Margonis, GA; Markatos, K; Moschos, MM; Nikiteas, N; Nonni, A; Perrea, D; Sampani, A; Schizas, D; Spartalis, E; Spartalis, M; Tsivelekas, K; Tsourouflis, G; Valsami, S | 1 |
Awada, R; Breton, D; Brulard, E; de Faria Maraschin, S; Etienne, H; Froger, S; Verdier, D | 1 |
2 review(s) available for scriptaid and trichostatin a
Article | Year |
---|---|
Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.
Topics: Animals; Antiparasitic Agents; Drug Repositioning; Helminth Proteins; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Leishmania; Plasmodium; Protozoan Proteins; Schistosoma; Toxoplasma; Trypanosoma | 2017 |
Targeting histone deacetylases in endometrial cancer: a paradigm-shifting therapeutic strategy?
Topics: Antineoplastic Agents; Endometrial Neoplasms; Endometrium; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Hydroxylamines; Quinolines | 2018 |
28 other study(ies) available for scriptaid and trichostatin a
Article | Year |
---|---|
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitors.
Topics: Amides; Cell Cycle; Cell Line, Tumor; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans | 2004 |
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
Topics: Animals; Antimalarials; Cluster Analysis; Computational Biology; Drug Evaluation, Preclinical; Drug Resistance; Folic Acid Antagonists; Malaria; Models, Molecular; Parasites; Plasmodium falciparum; Reproducibility of Results; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 2008 |
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.
Topics: Animals; Bronchi; Cell Membrane; Cricetinae; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Epithelial Cells; Gene Silencing; Histone Deacetylases; Humans; Hydroxamic Acids; Mutation; Protein Denaturation; Protein Folding; RNA, Small Interfering; Vorinostat | 2010 |
Chemical phylogenetics of histone deacetylases.
Topics: | 2010 |
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
Topics: Acute Lung Injury; Animals; Epoxide Hydrolases; Female; Histone Deacetylase Inhibitors; Idiopathic Pulmonary Fibrosis; Leukotriene B4; Mice; Mice, Inbred C57BL; Neutrophils | 2017 |
Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy.
Topics: Animals; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histone Deacetylases; In Vitro Techniques; Molecular Docking Simulation; Molecular Structure; Quantitative Structure-Activity Relationship; Schistosoma mansoni | 2017 |
Design and Synthesis of Tubulin and Histone Deacetylase Inhibitor Based on iso-Combretastatin A-4.
Topics: Antineoplastic Agents; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Design; HCT116 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; K562 Cells; Protein Conformation; Stilbenes; Tubulin | 2018 |
Highly fluorescent and HDAC6 selective scriptaid analogues.
Topics: Animals; Blood Vessels; Cytoplasm; Diagnostic Imaging; Fluorescence; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Hydroxylamines; Quinolines; Zebrafish | 2019 |
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.
Topics: Animals; Biomarkers; Cell Line; Epigenesis, Genetic; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Mice; Protein Processing, Post-Translational; Rare Diseases | 2020 |
Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Polymerization; Quinolines; Repressor Proteins; Tubulin | 2022 |
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.
Topics: Cell Survival; Chemistry, Organic; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Genes, Reporter; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Immunoblotting; Luciferases; Organic Chemistry Phenomena; Quinolines; Signal Transduction; Smad4 Protein; Trans-Activators; Transfection; Transforming Growth Factor beta; Tumor Cells, Cultured | 2000 |
Induction of human gamma globin gene expression by histone deacetylase inhibitors.
Topics: Amides; Enzyme Inhibitors; Gene Expression Regulation; Globins; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Peptides; Quinolines | 2004 |
Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid.
Topics: Anemia, Sickle Cell; Animals; Butyrates; Enzyme Inhibitors; Erythroid Precursor Cells; Fetal Hemoglobin; Gene Expression Regulation; Gene Silencing; Globins; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Imidazoles; K562 Cells; Mice; Mice, Transgenic; p38 Mitogen-Activated Protein Kinases; Pyridines; Quinolines; RNA, Messenger; Signal Transduction | 2005 |
Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
Topics: Acetylation; Animals; Apoptosis; Cardiomegaly; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Hydroxylamines; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Myosin Heavy Chains; Natriuretic Peptides; Protein Isoforms; Quinolines; Repressor Proteins; Time Factors; Ultrasonography; Ventricular Function | 2006 |
Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
Topics: Animals; Antiprotozoal Agents; Butyrates; Cattle; Cell Line; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Inhibitory Concentration 50; Niacinamide; Parasitic Sensitivity Tests; Phenylbutyrates; Quinolines; Toxoplasma; Valproic Acid; Vitamin B Complex; Vorinostat | 2007 |
Acetylation of histone H3 and adrenergic-regulated gene transcription in rat pinealocytes.
Topics: Acetylation; Adrenergic Agents; Adrenergic alpha-Agonists; Animals; Arylalkylamine N-Acetyltransferase; Cell Cycle Proteins; Cells, Cultured; Cyclic AMP Response Element Modulator; Drug Administration Schedule; Dual Specificity Phosphatase 1; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histones; Hydroxamic Acids; Hydroxylamines; Immediate-Early Proteins; Melatonin; Norepinephrine; Phosphoprotein Phosphatases; Pineal Gland; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins c-fos; Quinolines; Rats; RNA, Messenger; Transcription, Genetic | 2007 |
Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Hydroxylamines; Inflammation Mediators; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Nitric Oxide; Quinolines; RNA, Messenger; Time Factors | 2009 |
Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells.
Topics: Acetylation; Animals; Butyrates; CD4-Positive T-Lymphocytes; Cells, Cultured; Clonal Anergy; Cyclin-Dependent Kinase Inhibitor p21; Enzyme Induction; Histone Deacetylase Inhibitors; Hydroxamic Acids; Hydroxylamines; Mice; Mice, Inbred C57BL; Okadaic Acid; Quinolines; Th1 Cells | 2009 |
Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation.
Topics: Antigens, Nuclear; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; DNA Breaks, Double-Stranded; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Ku Autoantigen; Quinolines; Radiation; Radiation-Sensitizing Agents | 2010 |
Histone deacetylase inhibitors improve in vitro and in vivo developmental competence of somatic cell nuclear transfer porcine embryos.
Topics: Acetylation; Animals; Animals, Outbred Strains; Blastocyst; Cloning, Organism; Dose-Response Relationship, Drug; Embryo Culture Techniques; Embryo Transfer; Embryo, Mammalian; Embryonic Development; Enzyme Activation; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Hydroxylamines; Nuclear Transfer Techniques; Quinolines; Sus scrofa; Time Factors | 2010 |
Histone deacetylase inhibitors de-repress tyrosine hydroxylase expression in the olfactory bulb and rostral migratory stream.
Topics: Animals; Butyrates; Cell Movement; Green Fluorescent Proteins; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Hydroxylamines; Mice; Mice, Transgenic; Neurons; Olfactory Bulb; Prosencephalon; Quinolines; Stem Cells; Tyrosine 3-Monooxygenase | 2010 |
Treatment with a histone deacetylase inhibitor after nuclear transfer improves the preimplantation development of cloned bovine embryos.
Topics: Acetylation; Animals; Blastocyst; Cattle; Cell Line; Cloning, Organism; Ectogenesis; Embryo Culture Techniques; Fibroblasts; Histone Deacetylase Inhibitors; Histones; Hydroxamic Acids; Hydroxylamines; Nuclear Transfer Techniques; Oocytes; Osmolar Concentration; Quinolines; Time Factors | 2011 |
Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line.
Topics: Antigens, Surface; Benzamides; beta-Globins; Butyrates; Cell Differentiation; Cell Line, Tumor; Erythroid Precursor Cells; Fetal Hemoglobin; gamma-Globins; Gene Expression; Humans; Hydroxamic Acids; Hydroxylamines; Hydroxyurea; Imatinib Mesylate; K562 Cells; Piperazines; Pyrimidines; Quinolines; RNA, Messenger; Signal Transduction; Transcription Factors; Vorinostat | 2010 |
Enrichment of Nur77 mediated by retinoic acid receptor β leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors.
Topics: Antioxidants; Apoptosis; Carcinoma, Hepatocellular; Fenretinide; Hep G2 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Liver Neoplasms; Nuclear Receptor Subfamily 4, Group A, Member 1; Quinolines; Reactive Oxygen Species; Receptors, Retinoic Acid; RNA, Messenger | 2011 |
Histone deacetylase inhibition improves activation of ribosomal RNA genes and embryonic nucleolar reprogramming in cloned mouse embryos.
Topics: Animals; Cell Nucleolus; Cloning, Organism; Embryonic Development; Enzyme Inhibitors; Histone Deacetylases; Hydroxamic Acids; Hydroxylamines; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Models, Animal; Nuclear Transfer Techniques; Quinolines; RNA, Ribosomal; Transcriptional Activation | 2011 |
Synergistic effect of trichostatin A and scriptaid on the development of cloned rabbit embryos.
Topics: Animals; Cloning, Organism; Embryo Culture Techniques; Female; Gene Expression Regulation, Developmental; Hydroxamic Acids; Hydroxylamines; Male; Octamer Transcription Factor-3; Quinolines; Rabbits | 2013 |
Histone deacetylase inhibitors suppress immature dendritic cell's migration by regulating CC chemokine receptor 1 expression.
Topics: Animals; Butyric Acid; Cell Differentiation; Cell Movement; Cells, Cultured; Chemokine CCL3; Dendritic Cells; Down-Regulation; Histone Deacetylase Inhibitors; Hydroxamic Acids; Hydroxylamines; Mice; Mice, Inbred C57BL; Quinolines; Receptors, CCR1 | 2017 |
An innovative automated active compound screening system allows high-throughput optimization of somatic embryogenesis in Coffea arabica.
Topics: Automation, Laboratory; Coffea; High-Throughput Screening Assays; Histone Deacetylase Inhibitors; Hydroxamic Acids; Hydroxylamines; Miniaturization; Pilot Projects; Plant Cells; Plant Somatic Embryogenesis Techniques; Quinolines; Reproducibility of Results; Seeds | 2020 |